Playback speed
10 seconds
Immunotherapy in Locally Advanced NSCLC - PACIFIC Study Shows Durvalumab Improves Overall Survival
By
Beacon Medical Interchange
FEATURING
Jack West
By
Beacon Medical Interchange
FEATURING
Jack West
0 views
November 2, 2018
Dr. Jack West reviews the potential new role for immunotherapy in locally advanced NSCLC based ...
read more ↘ on the early report that the PACIFIC trial of durvalumab after chemo/radiation is positive for a significant improvement in progression-free survival.
↖ read less
read more ↘ on the early report that the PACIFIC trial of durvalumab after chemo/radiation is positive for a significant improvement in progression-free survival.
↖ read less
Comments 0
Login to view comments.
Click here to Login
Lung